stable coronary artery disease
Conditions
Interventions
Sponsors
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Meet the criteria of Western medicine diagnosis of coronary heart disease and TCM blood stasis syndrome differentiation; 2. From January 1, 2018 to December 31, 2020, those who have been treated with Chinese patent medicines for promoting blood circulation and removing blood stasis for more than 6 months or those who only receive conventional Western medicine treatment; 3. Age over 18 years old, no gender limit; 4. Participate voluntarily, be able to understand and comply with the trial protocol, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with severe wasting state or malignant tumors; 2. Women who are pregnant or breastfeeding or have pregnancy plans; 3. Patients with severe primary diseases such as liver, kidney, hematopoietic system, or mental illness; 4. Participants in other clinical trials in the past three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major Adverse Cardiovascular Events; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome; | — |
Countries
China
Contacts
Public ContactHongxu Liu
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Outcome results
None listed